WHO Terminates Hydroxychloroquine and Lopinavir/Ritonavir COVID-19 Treatment Trials
The WHO has discontinued hydroxychloroquine and lopinavir/ritonavir trials for hospitalized COVID-19 patients after interim results showed no significant…

International clinical trials for hydroxychloroquine and lopinavir/ritonavir as treatments for hospitalized COVID-19 patients have been discontinued. Interim results indicate these interventions provide little to no reduction in mortality compared to standard care protocols. Investigators have ceased these specific trial arms with immediate effect.
While the interim data did not confirm increased mortality, clinical laboratory findings from associated sub-trials identified safety signals. These findings will be detailed in forthcoming peer-reviewed publications. The decision to halt these arms is limited to the treatment of hospitalized patients.
This termination does not preclude the evaluation of these drugs in non-hospitalized settings or as prophylactic measures. The findings necessitate a shift in clinical research focus toward alternative therapeutic candidates for severe COVID-19 cases. Future institutional resource allocation should account for the lack of efficacy demonstrated by these specific pharmaceutical interventions.
More stories
- Dietitians advise small swaps for plant-based eating
- TikTok dementia videos mislead in 66.4% of sample, researchers say
- Aberdeen Royal Infirmary faces police inquiry call over 19 deaths
- Bariatric surgery group loses 28.2% after GLP-1 use
- TOFA boosts mouse energy use 18% while preserving muscle
- ICO probes NHS therapy notes accessible to up to 140,000 staff
- Silver diamine fluoride stops decay in over half of baby teeth
- B vitamins can turn urine fluorescent yellow
- GLP-1 users report nail detachment at 39% in survey
- Soy-derived LPC70 curbs salt-linked behavior changes in mice
Latest news
- Hull City 2–0 Brighton: When Resilience Beat Reputation
- David Parr House to honor Victorian art-workman with blue plaque
- Iran's attacks hit 25 tankers near Strait of Hormuz
- FCC approves prison cellphone jamming despite 2.5-mile warning
- Russia strikes Ukraine as Odesa faces electricity strain
- Bahrain reports two injuries after Iranian aerial attacks
- Congress tests Black Democrats' growing policy influence
- Baltic responders fight Sparta II fire after drone strike

